Anti-sortilin1 Antibody Up-Regulates Progranulin

frontotemporal dementia granulin (GRN) monoclonal antibody progranulin (PGRN) sortilin1 (SORT1)

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2020
Historique:
received: 22 07 2020
accepted: 16 11 2020
entrez: 1 1 2021
pubmed: 2 1 2021
medline: 2 1 2021
Statut: epublish

Résumé

Progranulin (PGRN) haploinsufficiency associated with loss-of-function mutations in the granulin gene causes frontotemporal dementia (FTD). This suggests that increasing PGRN levels could have promising therapeutic implications for patients carrying

Identifiants

pubmed: 33384578
doi: 10.3389/fnins.2020.586107
pmc: PMC7770147
doi:

Types de publication

Journal Article

Langues

eng

Pagination

586107

Informations de copyright

Copyright © 2020 Miyakawa, Sakuma, Warude, Asanuma, Arimura, Yoshihara, Tavares, Hata, Ida, Hori, Okuzono, Yamamoto, Iida, Shimizu, Kondo and Sato.

Déclaration de conflit d'intérêts

The authors of the publication were employees of the Takeda Pharmaceutical Company at the time the research was conducted.

Références

Eur J Neurol. 2010 Jan;17(1):143-6
pubmed: 19674067
J Biol Chem. 2011 May 6;286(18):16101-8
pubmed: 21454553
Front Neurosci. 2016 Nov 24;10:542
pubmed: 27932946
Neurobiol Aging. 2018 Feb;62:245.e9-245.e12
pubmed: 29146050
J Cell Biol. 2008 Apr 7;181(1):37-41
pubmed: 18378771
Cell Mol Life Sci. 2009 Aug;66(16):2677-89
pubmed: 19434368
NeuroRx. 2005 Jan;2(1):3-14
pubmed: 15717053
Hum Mol Genet. 2018 Feb 1;27(3):546-558
pubmed: 29186428
Bioconjug Chem. 2013 Oct 16;24(10):1741-9
pubmed: 24059813
Neurochem Int. 2004 Sep;45(4):545-52
pubmed: 15186921
Biochem Biophys Res Commun. 2008 Aug 22;373(2):292-7
pubmed: 18559255
J Alzheimers Dis. 2016 Jul 1;53(4):1353-63
pubmed: 27392867
Bioorg Med Chem Lett. 2014 Jan 1;24(1):177-80
pubmed: 24355129
Structure. 2019 Jul 2;27(7):1103-1113.e3
pubmed: 31104815
Mol Interv. 2003 Mar;3(2):90-105, 51
pubmed: 14993430
J Hepatol. 2015 Jan;62(1):175-81
pubmed: 25173968
eNeuro. 2017 Aug 18;4(4):
pubmed: 28828399
Brain. 2009 Mar;132(Pt 3):583-91
pubmed: 19158106
Cells. 2019 Mar 11;8(3):
pubmed: 30862089
Am J Pathol. 2010 Jul;177(1):311-24
pubmed: 20522652
J Pathol. 2012 Sep;228(1):67-76
pubmed: 22733568
J Neurochem. 2016 Aug;138 Suppl 1:32-53
pubmed: 27009575
J Neurosci. 2005 Jun 1;25(22):5455-63
pubmed: 15930396
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2820-4
pubmed: 7708731
Sci Transl Med. 2017 Apr 12;9(385):
pubmed: 28404863
Nature. 2004 Feb 26;427(6977):843-8
pubmed: 14985763
Neurology. 2008 Oct 14;71(16):1235-9
pubmed: 18768919
Neurobiol Aging. 2014 Jun;35(6):1473-82
pubmed: 24373676
SLAS Discov. 2018 Aug;23(7):656-666
pubmed: 29898633
Acta Crystallogr D Biol Crystallogr. 2014 Feb;70(Pt 2):451-60
pubmed: 24531479
Biochem Biophys Res Commun. 2016 Oct 21;479(3):551-556
pubmed: 27666481
Neurobiol Aging. 2018 Jun;66:181.e3-181.e10
pubmed: 29555433
Mol Neurodegener. 2017 Aug 23;12(1):62
pubmed: 28835281
Immunology. 2014 Jun;142(2):193-201
pubmed: 24383743
J Biomed Sci. 2017 Feb 20;24(1):15
pubmed: 28219375
Nat Rev Neurosci. 2017 Jun;18(6):325-333
pubmed: 28435163
J Clin Invest. 2012 Aug;122(8):2807-16
pubmed: 22751103
J Mol Neurosci. 2011 Nov;45(3):538-48
pubmed: 21691802
J Neurosci. 2011 Feb 2;31(5):1885-94
pubmed: 21289198
Curr Opin Lipidol. 2014 Oct;25(5):350-7
pubmed: 25101658
PLoS One. 2011;6(6):e21023
pubmed: 21698296
Front Pharmacol. 2019 Jan 15;9:1561
pubmed: 30697159
Front Microbiol. 2014 Sep 11;5:477
pubmed: 25309517
Cerebrospinal Fluid Res. 2008 May 14;5:10
pubmed: 18479516
Nat Rev Neurol. 2012 Aug;8(8):423-34
pubmed: 22732773
Hum Mutat. 2008 Apr;29(4):512-21
pubmed: 18183624
J Immunol Methods. 2007 Dec 1;328(1-2):204-14
pubmed: 17804011
Curr Opin Lipidol. 2015 Dec;26(6):598-600
pubmed: 26780014
Histol Histopathol. 2009 Apr;24(4):481-92
pubmed: 19224451
Protein Sci. 2014 Sep;23(9):1291-300
pubmed: 24985322
Neurology. 2014 May 27;82(21):1871-8
pubmed: 24771538
Brain. 2017 May 1;140(5):1447-1465
pubmed: 28379303
J Mol Neurosci. 2011 Nov;45(3):574-82
pubmed: 21892758
J Biol Chem. 1998 Oct 9;273(41):26273-6
pubmed: 9756851
Science. 2011 Apr 22;332(6028):478-84
pubmed: 21393509
Protein Expr Purif. 2017 Feb;130:55-62
pubmed: 27693922
Nature. 2010 Aug 5;466(7307):714-9
pubmed: 20686566
Nature. 2016 May 11;533(7603):411-5
pubmed: 27193687
Sci Adv. 2019 Jun 19;5(6):eaav9946
pubmed: 31223654
Neuropharmacology. 2020 Apr;166:107948
pubmed: 31962288
Neuron. 2010 Nov 18;68(4):654-67
pubmed: 21092856
Mol Neurodegener. 2016 Jun 24;11(1):46
pubmed: 27341800
J Biol Chem. 1994 Nov 4;269(44):27595-602
pubmed: 7961676
Acta Neuropathol. 2018 Jul;136(1):1-17
pubmed: 29744576
J Biol Chem. 1997 Feb 7;272(6):3599-605
pubmed: 9013611
Nat Rev Neurosci. 2003 Apr;4(4):299-309
pubmed: 12671646
Ann Neurol. 2009 May;65(5):603-9
pubmed: 19288468

Auteurs

Shuuichi Miyakawa (S)

Immunology Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Hiroyuki Sakuma (H)

Immunology Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Dnyaneshwar Warude (D)

Immunology Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Satomi Asanuma (S)

Immunology Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Naoto Arimura (N)

Immunology Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Tomoki Yoshihara (T)

Global Biologics Research, Takeda Pharmaceutical Company Limited, Cambridge, MA, United States.

Daniel Tavares (D)

Global Biologics Research, Takeda Pharmaceutical Company Limited, Cambridge, MA, United States.

Akito Hata (A)

Global Biologics Research, Takeda Pharmaceutical Company Limited, Cambridge, MA, United States.

Koh Ida (K)

Global Biologics Research, Takeda Pharmaceutical Company Limited, Cambridge, MA, United States.

Yuri Hori (Y)

Immunology Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Yuumi Okuzono (Y)

Immunology Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Syunsuke Yamamoto (S)

Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Koichi Iida (K)

Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Hisao Shimizu (H)

Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Shinichi Kondo (S)

Immunology Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Shuji Sato (S)

Immunology Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Classifications MeSH